News 23 abr 2024 BGG from China opens headquarters in Basel BGG is establishing new global headquarters in Basel, from which it plans to grow in Europe and the USA. The Beijing-based company is a supplier ...
News 10 nov 2023 Researchers heal wounds with lactobacilli Researchers from Switzerland and the USA have jointly developed a dressing that uses probiotics to eliminate pathogens in chronic wounds. The pro...
Aktuell 05 mai 2023 Alentis nimmt 105 Millionen Dollar ein Alentis Therapeutics hat in einer Finanzierungsrunde der Serie C 105 Millionen Dollar erhalten. Sie werden in die Phase I- und Phase II-Programme...
News 01 nov 2023 Bacthera’s Visp plant aims to revolutionize microbiome-based treatments In Visp, Bacthera’s MC4a Center of Excellence readies to manufacture transformative microbiome therapies, notably the Seres Therapteutics’ life-s...
News 25 out 2023 Mecaplast Swiss, 50 years of innovation in the canton of Fribourg With a rich history spanning five decades, Mecaplast Swiss has consistently proven itself as a leader in the plastic injection industry, particul...
News 20 out 2023 Xlife Sciences becomes main shareholder in 4D Lifetec Xlife Sciences, a listed accelerator and investor in innovative healthcare solutions, has made an investment totalling 23.3 million Swiss francs ...
News 24 out 2022 VectivBio raises 125 million US dollars in stock sale VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The biotechnology firm has generated gross proceeds...
News 17 abr 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News 18 out 2022 KetoSwiss secures capital increase of 4 million dollars KetoSwiss has banked a total of 4 million US dollars from investors. The Basel-based start-up develops products to alleviate neurological disease...
News 04 abr 2024 Galderma completes largest IPO on a global level in Q1 Galderma has banked nearly 2.3 billion Swiss francs following its listing on the SIX Swiss Exchange. The pharma firm was therefore responsible fo...
Aktuell 24 out 2022 VectivBio erlöst 125 Millionen Dollar aus Aktienverkauf VectivBio hat den Abschluss des Zeichnungsangebots für 16'700'000 Stammaktien bekanntgegeben. Damit erzielte die Biotechfirma einen Bruttoerlös v...
Aktuell 10 mai 2024 BioVersys erweitert Serie-C-Runde auf 44,9 Millionen Franken BioVersys verstärkt die Zusammenarbeit mit GSK, um die Entwicklung von Alpibectir zur Behandlung von Tuberkulose zu beschleunigen. GSK beteiligt ...
Fact Sheet 08 out 2021 Dietary and Health Supplements in Indonesia Indonesia is an attractive country for the dietary and health supplement market, both for domestic and imported products, due to its large popula...
Aktuell 18 out 2022 KetoSwiss erhöht Kapital um 4 Millionen Dollar KetoSwiss hat von Investoren 4 Millionen Dollar erhalten. Das Basler Start-up entwickelt Produkte zur Linderung neurologischer Erkankungen wie Mi...
News 18 jul 2023 AI uncovers drug to treat rare pediatric disease The University of Zurich has identified a way to help children suffering from cystinosis in partnership with Insilico Medicine and the company’s ...
Fact-Finding Mission Health Tech Business Mission to Finland 02 out 2023–05 out 2023 Helsinki Finlândia